Next 10 |
2023-06-06 07:48:35 ET Early-stage biotechnology company ANEW MEDICAL ( OTCPK:LEAS ) announces business combination with Redwoods Acquisition ( RWOD ). The pro forma enterprise value of the combined company is up to $94M, which includes up to $54M of cash held in the trust...
ANEW MEDICAL, INC. (OTC: LEAS) and Redwoods Acquisition Corp. (NASDAQ: RWOD) Entered into a Definitive Merger Agreement PR Newswire ANEW MEDICAL is developing a platform and commercializing novel gene therapies to alleviate and/or reverse the progression of neurodegenerative...
Gene therapy candidate for amyotrophic lateral sclerosis (ALS) demonstrates bioactivities in a murine model of the disease PR Newswire NEW YORK , March 13, 2023 /PRNewswire/ -- ANEW MEDICAL, INC . ("ANEW'' or the "Company"), a medical product development comp...
ANEW MEDICAL Receives Notification of Issuance of Alzheimer's Gene Therapy Patent and Claims by the European Patent Organization (EPO) PR Newswire NEW YORK , Dec. 26, 2022 /PRNewswire/ -- ANEW MEDICAL, INC., a technology and medical product holding company (OTC: ...
ANEW MEDICAL, INC. Acquires World Wide License to Treat Neurodegenerative Diseases Using a Longevity Protein and Gene Therapy Programs. PR Newswire NEW YORK , Dec. 7, 2022 /PRNewswire/ -- ANEW MEDICAL, INC. ("ANEW" or "the Company") (OTCPK:LEAS), a medical techno...
New York, New York--(Newsfile Corp. - November 7, 2022) - ANEW MEDICAL, INC., (OTC Pink: LEAS) , today announced that they will be attending the Q4 Investor Summit live in NYC at the Sheraton Times Square. During the presentation, Dr. Joseph Sinkule, CEO and Founder of ANEW MEDICAL, INC., w...
ANEW MEDICAL, INC. Acquires Five Drug Approvals with Manufacturing in Europe PR Newswire NEW YORK , Oct. 4, 2022 /PRNewswire/ -- ANEW MEDICAL, INC. ("ANEW" or "the Company") (OTCPK: LEAS) announced that it has acquired five market-approved anti-cancer dru...
New York, New York--(Newsfile Corp. - April 29, 2022) - ANEW MEDICAL, INC., (OTC Pink: LEAS) today announced that Dr. Joseph Sinkule, the CEO and Founder of ANEW MEDICAL INC. (ANEW), will be attending and presenting at The Q2 Investor Summit Group - In-Person. ANEW is focused on completing a...
CHEYENNE, WY / ACCESSWIRE / December 21, 2020 / Strategic Asset Leasing Inc. (OTC PINK:LEAS), the Company, is pleased to announce an upcoming change in control of the Company. The Company has sold assets resulting in the appointment of a new management team. The transition is set to take ef...
CHEYENNE, WY / ACCESSWIRE / October 14, 2020 / Strategic Asset Leasing Inc. (OTC PINK:LEAS), the Company, is pleased to announce a shareholder update. The Company has begun formation of an advisory board. The advisory board will consist of key personnel with a range of expertise in their re...
News, Short Squeeze, Breakout and More Instantly...
Strategic Asset Leasing Inc. Company Name:
LEAS Stock Symbol:
OTCMKTS Market:
ANEW MEDICAL, INC. (OTC: LEAS) and Redwoods Acquisition Corp. (NASDAQ: RWOD) Entered into a Definitive Merger Agreement PR Newswire ANEW MEDICAL is developing a platform and commercializing novel gene therapies to alleviate and/or reverse the progression of neurodegenerative...
Gene therapy candidate for amyotrophic lateral sclerosis (ALS) demonstrates bioactivities in a murine model of the disease PR Newswire NEW YORK , March 13, 2023 /PRNewswire/ -- ANEW MEDICAL, INC . ("ANEW'' or the "Company"), a medical product development comp...
ANEW MEDICAL Receives Notification of Issuance of Alzheimer's Gene Therapy Patent and Claims by the European Patent Organization (EPO) PR Newswire NEW YORK , Dec. 26, 2022 /PRNewswire/ -- ANEW MEDICAL, INC., a technology and medical product holding company (OTC: ...